ARCHIVES

Raloxifene Protects Women At High or Low Risk of Disease

This article is from The Cancer Letter archive.

Vol. 29 No. 9 | September 29, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

February 24, 1989

NCI Plans Trials of Burzynski’s ‘Antineoplaston’; JAMA Report Says No Antitumor Activity In Tests

June 5, 1992

Phase III Trial of Avastin and Temozolomide Shows Reduced Risk of Cancer Progression

November 30, 2012

No Cancer Letter for Two Weeks

August 13, 1993

After Aggressive Budgetary Trimming, At $33 Million NCI’s caBIG Remains Big

December 2, 2011

Univ. Of Alabama Resident to Be New HEW Secretary

June 20, 1975